Neuromyelitis Optica Spectrum Disorder and Autoimmune Rheumatological Diseases: A Report of Two Cases and Literature Review

被引:1
|
作者
Faisal, Mohannad [1 ]
Matarneh, Ahmad [1 ]
Alshahwani, Israa [2 ]
Al-Allaf, Omar [3 ]
Al-Allaf, Abdul-wahab [4 ]
机构
[1] Hamad Med Corp, Internal Med, Doha, Qatar
[2] Hamad Med Corp, Gen Practice, Doha, Qatar
[3] New Cross Hosp, Rheumatol, Wolverhampton, England
[4] Hamad Med Corp, Rheumatol, Doha, Qatar
关键词
nmosd; sjogren's syndrome; rheumatology & autoimmune diseases; devic's disease; behcet's syndrome; neuromyelitis optica spectrum disorder; DIAGNOSTIC-CRITERIA; BEHCETS-DISEASE;
D O I
10.7759/cureus.26138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder, and its association with other autoinflammatory diseases has been reported in this study. In this article, we are discussing two patients with neuromyelitis optica who show evidence of autoimmune rheumatic diseases. The first case presented with acute myelitis and was diagnosed with NMOSD; she developed clinical features of Behcet's disease during follow-up, making it the second reported case worldwide. The second case presented with neuromyelitis optica and was found to have strongly positive Sjogren's serology.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Neuromyelitis optica spectrum disorder - case report
    Sciegienna-Zdeb, Grazyna
    Mierzwa-Molenda, Marta
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2016, 32 (01) : 45 - 48
  • [22] MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature
    Ikeda, Azusa
    Watanabe, Yoshihiro
    Kaba, Hikari
    Kaneko, Kimihiko
    Takahashi, Toshiyuki
    Takeshita, Saoko
    BRAIN & DEVELOPMENT, 2019, 41 (04): : 367 - 372
  • [23] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Fung, Simon
    Shirley, Matt
    CNS DRUGS, 2023, 37 (04) : 363 - 370
  • [24] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Simon Fung
    Matt Shirley
    CNS Drugs, 2023, 37 : 363 - 370
  • [25] Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Tina Nie
    Hannah A. Blair
    CNS Drugs, 2022, 36 : 1133 - 1141
  • [26] Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Nie, Tina
    Blair, Hannah A.
    CNS DRUGS, 2022, 36 (10) : 1133 - 1141
  • [27] Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Frampton, James E.
    DRUGS, 2020, 80 (07) : 719 - 727
  • [28] Neuromyelitis optica and autoimmune diseases
    Kattah, Jorge C.
    Gujrati, Meena
    ARCHIVES OF NEUROLOGY, 2008, 65 (07) : 995 - 996
  • [29] Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases
    Edgar Carnero Contentti
    Pablo A. López
    Juan Pablo Pettinicchi
    Verónica Tkachuk
    Vanessa Daccach Marques
    Ibis Soto de Castillo
    Edgardo Cristiano
    Liliana Patrucco
    Alejandro Caride
    Juan Ignacio Rojas
    Neurological Sciences, 2023, 44 : 1731 - 1737
  • [30] Neuromyelitis optica spectrum standstill in rheumatic systemic autoimmune diseases
    Elnady, Basant
    Fathy, Sabry M.
    Elkhouly, Tohamy
    Ganeb, Sahar
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2020, 47 (01)